OrbusNeich enrolls the 1st U.S. patient in a pivotal trial of its Combo dual-therapy coronary stent.
OrbusNeich Medical said today that it enrolled the 1st U.S. patient in a pivotal trial of its dual-therapy Combo stent.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1IMxEQB
Cap comentari:
Publica un comentari a l'entrada